$Kinnate BioPharma Inc.(KNTE)$

A new pharmaceutical star or dust??[serious]

A biopharmaceutical company focused on the discovery and development of small molecules kinase inhibitors for difficult to treat, genomically defined cancers.

Listed on December 2020 only

Key ratio [Drowsy]

-basically the fundamental is still not solid with all the key ratio in bad numbers

-total debt to equity ratio 0.15

-negative fcf

Technical

-overall a down trend[Weak]

- short term wise rising trend with higher low value

-crossing above ema30 and 60 , approaching ema200[Put]

Next earning report in 15/8/2022

With all the past 6 quarters earning reports consecutively missed the estimate, will it continue the same or have a breakthrough?? [Doubt]

Surpassing the ema200 for first time ever since listed??[Thinking]

@Daily_Discussion @TigerPM @TigerStars @CaptainTiger

US Stocks Opportunities

Here are a theme that collects the best quality or your most bullish US stocks, Share your thoughts here!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

PandoraHaggai
2022-08-09
PandoraHaggai
I'm looking forward to Kinnate's next financial report.
Maria_yy
2022-08-09
Maria_yy
It doesn't look like Kinnate is worth the investment.
HilaryWilde
2022-08-09
HilaryWilde
Hopefully Kinnate will surpass EMA200 soon
EvanHolt
2022-08-09
EvanHolt
I'm not happy with its cash flow.
ElvisMarner
2022-08-09
ElvisMarner
The biomedical industry is my favorite.
kytphine
2022-08-07
kytphine
thx for sharing

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":9905851465,"tweetId":"9905851465","gmtCreate":1659855752961,"gmtModify":1703767145632,"author":{"id":4105176218307480,"authorId":4105176218307480,"authorIdStr":"4105176218307480","name":"iceflower","avatar":"https://community-static.tradeup.com/news/a4440741d52458b3a0043bbe99d2075c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.12","individualDisplayEnabled":0},"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"84ac2c57901b463da0573a608cc0b2a5","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"US Stocks Opportunities","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":84ac2c57901b463da0573a608cc0b2a5}&rnconfig={\"headerBarHidden\": true}","description":"Here are a theme that collects the best quality or your most bullish US stocks, Share your thoughts here!","image":"https://static.tigerbbs.com/09d268d2d1fb9f45eacf5430006f3845"}],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a href=\"https://ttm.financial/S/KNTE\">$Kinnate BioPharma Inc.(KNTE)$</a> A new pharmaceutical star or dust??[serious]&nbsp; A biopharmaceutical company focused on the discovery and development of small molecules kinase inhibitors for difficult to treat, genomically defined cancers. Listed on December 2020 only Key ratio&nbsp;[Drowsy]&nbsp;-basically the fundamental is still not solid with all the key ratio in bad numbers-total debt to equity ratio 0.15-negative fcf Technical-overall a down trend[Weak]&nbsp;- short term wise rising trend&nbsp; with higher low value-crossing above ema30 and 60 , approaching ema200[Put]&nbsp; Next earning report in 15/8/2022 With all the past 6 quarters earning reports consecutively missed the estimate, will it continue the same or have a breakthrough??&nbsp;[Doubt]&nbsp; Surpassing the ema200 for first time ever since listed??[Thinking]&nbsp; <a href=\"https://ttm.financial/U/3527667621665671\">@Daily_Discussion</a><a href=\"https://ttm.financial/U/3527667588142897\">@TigerPM</a><a href=\"https://ttm.financial/U/9000000000000149\">@TigerStars</a><a href=\"https://ttm.financial/U/3527667618000160\">@CaptainTiger</a> </body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/KNTE\">$Kinnate BioPharma Inc.(KNTE)$</a> A new pharmaceutical star or dust??[serious]&nbsp; A biopharmaceutical company focused on the discovery and development of small molecules kinase inhibitors for difficult to treat, genomically defined cancers. Listed on December 2020 only Key ratio&nbsp;[Drowsy]&nbsp;-basically the fundamental is still not solid with all the key ratio in bad numbers-total debt to equity ratio 0.15-negative fcf Technical-overall a down trend[Weak]&nbsp;- short term wise rising trend&nbsp; with higher low value-crossing above ema30 and 60 , approaching ema200[Put]&nbsp; Next earning report in 15/8/2022 With all the past 6 quarters earning reports consecutively missed the estimate, will it continue the same or have a breakthrough??&nbsp;[Doubt]&nbsp; Surpassing the ema200 for first time ever since listed??[Thinking]&nbsp; <a href=\"https://ttm.financial/U/3527667621665671\">@Daily_Discussion</a><a href=\"https://ttm.financial/U/3527667588142897\">@TigerPM</a><a href=\"https://ttm.financial/U/9000000000000149\">@TigerStars</a><a href=\"https://ttm.financial/U/3527667618000160\">@CaptainTiger</a> </body></html>","text":"$Kinnate BioPharma Inc.(KNTE)$ A new pharmaceutical star or dust??[serious] A biopharmaceutical company focused on the discovery and development of small molecules kinase inhibitors for difficult to treat, genomically defined cancers. Listed on December 2020 only Key ratio [Drowsy] -basically the fundamental is still not solid with all the key ratio in bad numbers -total debt to equity ratio 0.15 -negative fcf Technical -overall a down trend[Weak] - short term wise rising trend with higher low value -crossing above ema30 and 60 , approaching ema200[Put] Next earning report in 15/8/2022 With all the past 6 quarters earning reports consecutively missed the estimate, will it continue the same or have a breakthrough?? [Doubt] Surpassing the ema200 for first time ever since listed??[Thinking] @Daily_Discussion@TigerPM@TigerStars@CaptainTiger","highlighted":2,"essential":2,"paper":1,"likeSize":34,"commentSize":44,"repostSize":1,"favoriteSize":0,"link":"https://ttm.financial/post/9905851465","repostId":0,"isVote":1,"tweetType":1,"viewCount":1374,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["KNTE"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":728,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":103327010,"gmtCreate":1660058538020,"gmtModify":1663255924645,"authorId":9000000000000431,"author":{"id":9000000000000431,"authorId":9000000000000431,"name":"PandoraHaggai","avatar":"https://static.tigerbbs.com/0eb1ca619238a10298cbe1a12b942794","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"I'm looking forward to Kinnate's next financial report.","text":"I'm looking forward to Kinnate's next financial report.","html":"I'm looking forward to Kinnate's next financial report.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":103327004,"gmtCreate":1660058525101,"gmtModify":1663255924644,"authorId":9000000000000478,"author":{"id":9000000000000478,"authorId":9000000000000478,"name":"Maria_yy","avatar":"https://static.tigerbbs.com/0cd35158209bf23b606a5949a0e97781","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"It doesn't look like Kinnate is worth the investment.","text":"It doesn't look like Kinnate is worth the investment.","html":"It doesn't look like Kinnate is worth the investment.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":103327015,"gmtCreate":1660058544861,"gmtModify":1663255925248,"authorId":9000000000000562,"author":{"id":9000000000000562,"authorId":9000000000000562,"name":"HilaryWilde","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"Hopefully Kinnate will surpass EMA200 soon","text":"Hopefully Kinnate will surpass EMA200 soon","html":"Hopefully Kinnate will surpass EMA200 soon","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":103327006,"gmtCreate":1660058530982,"gmtModify":1663255924644,"authorId":9000000000000592,"author":{"id":9000000000000592,"authorId":9000000000000592,"name":"EvanHolt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"I'm not happy with its cash flow.","text":"I'm not happy with its cash flow.","html":"I'm not happy with its cash flow.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":103327002,"gmtCreate":1660058517382,"gmtModify":1663255924727,"authorId":9000000000000601,"author":{"id":9000000000000601,"authorId":9000000000000601,"name":"ElvisMarner","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"The biomedical industry is my favorite.","text":"The biomedical industry is my favorite.","html":"The biomedical industry is my favorite.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":103287513,"gmtCreate":1659856731665,"gmtModify":1663255741648,"authorId":4101272829284430,"author":{"id":4101272829284430,"authorId":4101272829284430,"name":"kytphine","avatar":"https://static.tigerbbs.com/a86195df1a2eaba92724a209c195e50d","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9905851465,"type":1,"supId":0,"prevId":0,"content":"thx for sharing","text":"thx for sharing","html":"thx for sharing","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/9905851465"}